How to Manage Drug Interactions in Clinical Settings (3)

Kenji Momo , Atsushi Yonezawa , Takuya Iwamoto , Yoshiyuki Ohno , Takeshi Kimura , Akihiro Hisaka 7 and Kiyomi Ito 8 The First Academic Subcommittee of Japanese Society of Pharmaceutical Health Care and Sciences , Department of Pharmacy, The Institute of Medical Science Hospital, The University of Tokyo , Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital , Department of Pharmacy, Mie University Hospital, Faculty of Medicine, Mie University , Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo , Department of Pharmacy, Kobe University Hospital , Laboratory of Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University , Research Institute of Pharmaceutical Sciences, Musashino University 8

[1]  Katsuhisa Inoue,et al.  Osmolality of Orally Administered Solutions Influences Luminal Water Volume and Drug Absorption in Intestine. , 2017, Journal of pharmaceutical sciences.

[2]  V. Madhugiri,et al.  Incidence of Potential Drug-Drug Interactions in a Limited and Stereotyped Prescription Setting - Comparison of Two Free Online Pharmacopoeias , 2016, Cureus.

[3]  Jocelyn R. Wilder,et al.  Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011. , 2016, JAMA internal medicine.

[4]  M. Ryan,et al.  Pharmacologic Therapy for Posttraumatic Stress Disorder: Review of Prescriptions and Potential Drug-Drug Interactions in a Military Cohort. , 2015, The Primary Care Companion For CNS Disorders.

[5]  Hartmut Derendorf,et al.  Enzyme‐ and transporter‐mediated beverage–drug interactions: An update on fruit juices and green tea , 2015, Journal of clinical pharmacology.

[6]  P. Stoll,et al.  Potential drug–drug interactions in hospitalized patients undergoing systemic chemotherapy: a prospective cohort study , 2015, International Journal of Clinical Pharmacy.

[7]  Yusuke Masuo,et al.  NPC1L1 is a key regulator of intestinal vitamin K absorption and a modulator of warfarin therapy , 2015, Science Translational Medicine.

[8]  E. Kopel,et al.  Potential drug interactions in travelers with chronic illnesses: a large retrospective cohort study. , 2014, Travel medicine and infectious disease.

[9]  D. Provenzano,et al.  Complexity of Pain Management Among Patients with Nociceptive or Neuropathic Neck, Back, or Osteoarthritis Diagnoses , 2014, Journal of managed care & specialty pharmacy.

[10]  J. Pergolizzi,et al.  The Prevalence of Opioid-Related Major Potential Drug-Drug Interactions and Their Impact on Health Care Costs in Chronic Pain Patients , 2014, Journal of managed care & specialty pharmacy.

[11]  Edward P. Armstrong,et al.  Evaluation of a drug-drug interaction: fax alert intervention program , 2013, BMC Medical Informatics and Decision Making.

[12]  M. Fisch,et al.  Evaluation of drug interactions in patients treated with antidepressants at a tertiary care cancer center , 2012, Supportive Care in Cancer.

[13]  A. Forster,et al.  Incidence and Contributors to Potential Drug‐Drug Interactions in Hospitalized Patients , 2011, Journal of clinical pharmacology.

[14]  K. Seden,et al.  Prevalence of Potential Drug-Drug Interactions Involving Antiretroviral Drugs in a Large Kenyan Cohort , 2011, PloS one.

[15]  C. Moura,et al.  Potential Drug-Drug Interactions Associated with Prolonged Stays in the Intensive Care Unit , 2011, Clinical drug investigation.

[16]  W. Terpstra,et al.  Potential drug–drug interactions between anti-cancer agents and community pharmacy dispensed drugs , 2010, Pharmacy World & Science.

[17]  Ethan Basch,et al.  The missing voice of patients in drug-safety reporting. , 2010, The New England journal of medicine.

[18]  D. Berlowitz,et al.  Choice of Initial Antiepileptic Drug for Older Veterans: Possible Pharmacokinetic Drug Interactions with Existing Medications , 2010, Journal of the American Geriatrics Society.

[19]  M. Dickson,et al.  Potential drug-drug interactions with antiepileptic drugs in Medicaid recipients. , 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[20]  Göran Petersson,et al.  Potential drug interactions during a three-decade study period: a cross-sectional study of a prescription register , 2007, European Journal of Clinical Pharmacology.

[21]  Göran Petersson,et al.  Detection of potential drug interactions – a model for a national pharmacy register , 2006, European Journal of Clinical Pharmacology.

[22]  G R Wilkinson,et al.  OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[23]  D. Bailey,et al.  Grapefruit juice-drug interactions. , 1998, British journal of clinical pharmacology.

[24]  B. Pomeranz,et al.  Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. , 1998, JAMA.

[25]  L. Bergendal,et al.  Potential drug-drug interactions in 5,125 mostly elderly out-patients in Gothenburg, Sweden , 1995, Pharmacy World and Science.

[26]  Wei Duan,et al.  Herb-Drug Interactions , 2012, Drugs.